Manuella Salustiano Andrade Barros

Ms. Manuella Salustiano Andrade Barros

Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
MFMaria Helena Fermiano
Maria Helena Fermiano
ANAmarith Rodrigues das Neves
Amarith Rodrigues das Neves
FSFernanda da Silva
Fernanda da Silva
Manuella Salustiano Andrade BarrosManuella Salustiano Andrade Barros
Manuella Salustiano Andrade Barros
CVCamila Barbosa Vieira
Camila Barbosa Vieira
TRThalita Riul
Thalita Riul
Leishmaniasis remains a significant global health concern, with current treatments relying on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and drug resistance. Consequently, the urgent need for safer and more effective therapeutic options in leishmaniasis treatment persists. Previous research has highlighted selenium compounds as promising candidates for innovative leishmaniasis therapy. In light of this, a library of 10 selenium-containing diverse compounds was designed and evaluated in this study. These compounds included selenium-substituted indole, coumarin, chromone, oxadiazole, imidazo[1,2-a]pyridine, Imidazo[2,1-b]thiazole, and oxazole, among others. These compounds were screened against Leishmania amazonensis promastigotes and intracellular amastigotes, and their cytotoxicity was assessed in peritoneal macrophages, NIH/3T3, and J774A.1 cells. Among the tested compounds, MRK-106 and MRK-108 displayed the highest potency against L. amazonensis promastigotes with reduced cytotoxicity. Notably, MRK-106 and MRK-108 exhibited IC50 values of 3.97 µM and 4.23 µM, respectively, and most of the tested compounds showed low cytotoxicity in host cells (CC50 > 200 µM). Also, compounds MRK-107 and MRK-113 showed activity against intracellular amastigotes (IC50 18.31 and 15.93 µM and SI 12.55 and 10.92, respectively). In conclusion, the identified selenium-containing compounds hold potential structures as antileishmanial drug candidates to be further explored in subsequent studies. These findings represent a significant step toward the development of safer and more effective therapies for leishmaniasis, addressing the pressing need for novel and improved treatments.

12 November 2026 in Appliedchem
Verified
Journal Article
Open access
PDF file
Manuella Salustiano Andrade BarrosManuella Salustiano Andrade Barros
Manuella Salustiano Andrade Barros
LVLetícia Caroline Candida Vaz
Letícia Caroline Candida Vaz
GGGuilherme Camargo Gomes
Guilherme Camargo Gomes
RGRanielle Walisson Alves Gomes
Ranielle Walisson Alves Gomes
POPaola Dias de Oliveira
Paola Dias de Oliveira
GAGlaucia Braz Alcantara
Glaucia Braz Alcantara
Coconut oil is a commercially important vegetable oil whose composition is relevant to food quality assessment. This study explored the complementary use of Attenuated Total Reflectance-Fourier Transform Infrared (ATR-FTIR) and proton nuclear magnetic resonance (1H NMR) spectroscopy, combined with principal component analysis (PCA), to characterize commercial coconut oils marketed in Brazil. Thirteen commercial samples available during the sampling period were analyzed, alongside an in-house coconut oil reference and comparison oils. The spectral patterns were interpreted in relation to fatty-acid composition, including features associated with unsaturated fatty acids. Most coconut oil samples clustered close to the reference sample, despite different brands, whereas two samples exhibited spectral profiles more similar to palm kernel oil than to the reference coconut oil. These observations describe similarities in the measured spectral profiles and do not establish adulteration. Overall, these findings highlight the complementary potential of 1H NMR and FTIR spectroscopy combined with chemometrics for the exploratory chemical characterization of coconut oils commercially available in Brazil. Further studies involving more reference samples and independent validation are required before authentication performance.

21 December 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
MFMaria Helena Fermiano
Maria Helena Fermiano
ANAmarith Rodrigues Das Neves
Amarith Rodrigues Das Neves
FSFernanda Da Silva
Fernanda Da Silva
Manuella Salustiano Andrade BarrosManuella Salustiano Andrade Barros
Manuella Salustiano Andrade Barros
CVCamila Barbosa Vieira
Camila Barbosa Vieira
TRThalita Riul
Thalita Riul
Leishmaniasis remains a significant global health concern, with current treatments relying on outdated drugs associated with high toxicity, lengthy administration, elevated costs, and drug resistance. Consequently, the urgent need for safer and more effective therapeutic options in leishmaniasis treatment persists. Previous research has highlighted selenium compounds as promising candidates for innovative leishmaniasis therapy. In light of this, a library of 10 selenium-containing diverse compounds was designed and evaluated in this study. The compounds were subjected to screening against L. amazonensis promastigotes, and their cytotoxicity was assessed in NIH/3T3 cells. Among the tested compounds, MRK-106 and MRK-108 displayed the highest potency against L. amazonensis promastigotes while demonstrating reduced cytotoxicity. Notably, MRK-106 and MRK-108 exhibited IC50 values of 3.97 µM, 4.23 µM, respectively, and most of the tested compounds showed low cytotoxicity in NIH/3T3 cells (CC50 > 200 µM). Although these results are promising, additional investigations focusing on intracellular amastigotes are required to determine the antileishmanial activity of the compounds. In conclusion, the identified selenium-containing compounds hold considerable potential as antileishmanial drug candidates and warrant further exploration in subsequent studies. These findings represent a significant step towards the development of safer and more effective therapies for leishmaniasis, addressing the pressing need for novel and improved treatments.